Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan;55(1):64-7.
doi: 10.4103/0019-5049.76598.

Anaesthetic management in a patient with multiple sclerosis

Lata M Kulkarni  1 , Cs Sanikop, Hl Shilpa, Anupama Vinayan
Affiliations

Anaesthetic management in a patient with multiple sclerosis

Lata M Kulkarni et al. Indian J Anaesth. 2011 Jan.

Abstract

Multiple sclerosis (MS) is a rare autoimmune demyelinating disorder of the central nervous system clinically manifesting as periodic attacks of varied neurologic symptoms, eventually progressing to fixed neurologic deficits and disability. The treatment is symptomatic and directed towards prevention of future progression of the disease involving multiple agents. We present here a case report of a patient with MS who underwent an orthopaedic procedure under general anaesthesia (G.A.) uneventfully. Anaesthetic implications include assessment of neurological deficits with documentation pre- and postoperatively, awareness towards side-effects, potential drug interactions of medications, selection of suitable techniques/anaesthetic agents, neuromuscular monitoring-guided titration of non-depolarizing blocking agents with lowest necessary dose and avoidance of hyperthermia along with temperature, haemodynamic and respiratory monitoring. Lower concentrations of local anaesthetic (LA) should be used for regional blocks keeping in mind the susceptibility of demyelinated neurons, towards LA neurotoxicity. To the best of our knowledge, this is the first report of anaesthetic management of MS in India.

Keywords: Anaesthetic; demyelination; multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared

References

    1. Harser SL, Goodin DS. Harrison’s Principles of Internal Medicine. 17th ed. Vol. 2. New York, London: Mcgraw Hill Medical; 2008. Multiple sclerosis and demyelinating diseases; pp. 2611–20.
    1. Dierdoff SF, Scott Walton J. Anesthesia for patients with rare and co-existing diseases. In: Barash PG, Cullen BF, Stoelting RK, editors. Clinical Anesthesia. 5th ed. Philadelphia: Lippincott, Williams & Wilkins; 2006. pp. 510–1.
    1. Dorotta IR, Schubert A. Multiple sclerosis and anesthetic implications. Curr Opin Anaesthesiol. 2002;15:365–70. - PubMed
    1. Perlas A, Chan VW. Neuraxial anesthesia and multiple sclerosis. Can J Anaesth. 2005;52:454–8. - PubMed
    1. Stoelting RK, Dierdoff SF. Diseases of nervous system in anesthesia and co-existing disease. 4th ed. Philadelphia: Churchill-Livingstone; 2004. pp. 268–9.